The average one-year price target for Genscript Biotech (OTCPK:GNNSF) has been revised to $3.32 / share. This is an increase of 16.00% from the prior estimate of $2.86 dated April 1, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $2.92 to a high of $4.06 / share. The average price target represents an increase of 216.07% from the latest reported closing price of $1.05 / share.
What is the Fund Sentiment?
There are 80 funds or institutions reporting positions in Genscript Biotech. This is an increase of 3 owner(s) or 3.90% in the last quarter. Average portfolio weight of all funds dedicated to GNNSF is 0.08%, an increase of 8.78%. Total shares owned by institutions increased in the last three months by 7.33% to 79,867K shares.
What are Other Shareholders Doing?
VGTSX - Vanguard Total International Stock Index Fund Investor Shares holds 17,264K shares representing 0.79% ownership of the company. In its prior filing, the firm reported owning 18,342K shares , representing a decrease of 6.24%. The firm increased its portfolio allocation in GNNSF by 35.12% over the last quarter.
VEIEX - Vanguard Emerging Markets Stock Index Fund Investor Shares holds 16,304K shares representing 0.75% ownership of the company. In its prior filing, the firm reported owning 16,644K shares , representing a decrease of 2.09%. The firm increased its portfolio allocation in GNNSF by 33.96% over the last quarter.
IEMG - iShares Core MSCI Emerging Markets ETF holds 10,350K shares representing 0.47% ownership of the company. In its prior filing, the firm reported owning 10,218K shares , representing an increase of 1.28%. The firm decreased its portfolio allocation in GNNSF by 6.34% over the last quarter.
DFCEX - Emerging Markets Core Equity Portfolio - Institutional Class holds 3,884K shares representing 0.18% ownership of the company. In its prior filing, the firm reported owning 1,078K shares , representing an increase of 72.25%. The firm increased its portfolio allocation in GNNSF by 132.96% over the last quarter.
MCHI - iShares MSCI China ETF holds 3,468K shares representing 0.16% ownership of the company. In its prior filing, the firm reported owning 3,342K shares , representing an increase of 3.63%. The firm decreased its portfolio allocation in GNNSF by 0.22% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
